GLP-1 drugs for diabetes and weight loss are difficult for some people to inject weekly. A new slow-release gel, tested in rats, could help.

FMP, the University of Oxford, and the University of Birmingham have developed a novel imaging approach to track how popular ...

A new imaging approach reveals how dual agonist drugs like tirzepatide act on the pancreas and brain to regulate blood sugar and appetite.

Researchers have developed fluorescent probes, daLUXendins, to track dual agonist drugs like tirzepatide in live tissues. The ...

Treating patients who have type 2 diabetes and atherosclerotic cardiovascular disease with tirzepatide (Mounjaro) results in MACE rates similar to those seen with the older diabetes drug dulaglutide ...

Topline data were announced from a head-to-head phase 3 trial evaluating tirzepatide vs dulaglutide in adults with type 2 diabetes (T2D) and established atherosclerotic cardiovascular disease ...

Scholar Rock Holding Corporation (NASDAQ:SRRK) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Scholar Rock ...

Once-weekly tirzepatide conferred a similar cardiovascular risk as once-weekly dulaglutide in adults with type 2 diabetes and established atherosclerotic cardiovascular disease, according to ...

Tirzepatide vs. liraglutide Between tirzepatide and liraglutide, the risk for incident composite MACEs was significantly lower with tirzepatide (HR = 0.58; 95% CI, 0.51-0.66).